Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 14α-demethylase (CYP51) is a highly conserved enzyme crucial for sterol biosynthesis across all biological kingdoms. It catalyzes the removal of the 14α-methyl group from sterol precursors like lanosterol or obtusifoliol, a critical step in producing essential membrane sterols (ergosterol in fungi, cholesterol in animals). As a major target for azole antifungals, inhibiting CYP51 disrupts fungal cell viability. However, resistance mechanisms such as mutations or overexpression pose a significant clinical challenge.
Inhibition of ergosterol synthesis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 14α-Demethylase (CYP51).